(Q74818970)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11665587%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

title

Design and synthesis of peptide antagonists and inverse agonists for G protein-coupled receptors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11665587%20AND%20SRC:MED&resulttype=core&format=json

G protein-coupled receptor

13 November 2019

main subject

1 reference

Scott M Cowell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11665587%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Preeti M Balse-Srinivasan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11665587%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Jung-Mo Ahn

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11665587%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Victor J Hruby

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11665587%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11665587%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

published in

Methods in Enzymology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11665587%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

volume

343

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11665587%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

page(s)

49-72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11665587%20AND%20SRC:MED&resulttype=core&format=json

Molecular organization of receptors. Efficacy, agonists, and antagonists

13 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Conformational restrictions of biologically active peptides via amino acid side chain groups

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Emerging approaches in the molecular design of receptor-selective peptide ligands: conformational, topographical and dynamic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Conformational and topographical considerations in the design of biologically active peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Design of peptides, proteins, and peptidomimetics in chi space.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Conformation of glucagon in a lipid-water interphase by 1H nuclear magnetic resonance

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Structure-function studies on positions 17, 18, and 21 replacement analogues of glucagon: the importance of charged residues and salt bridges in glucagon biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

The role of phenylalanine at position 6 in glucagon's mechanism of biological action: multiple replacement analogues of glucagon

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Hyperglycemia of Diabetic Rats Decreased by a Glucagon Receptor Antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Low level cyclic adenosine 3',5'-monophosphate accumulation analysis of [des-His1, des- Phe6, Glu9] glucagon-NH2 identifies glucagon antagonists from weak partial agonists/antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

A highly sensitive adenylate cyclase assay

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Structure-function relations in glucagon. Properties of highly purified Des-his1-, monoiodo-, and [Des-Asn28,Thr29](homoserine lactone27)-glucagon

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Challenge of hepatocytes by glucagon triggers a rapid modulation of adenylate cyclase activity in isolated membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

The cloning of a family of genes that encode the melanocortin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Molecular cloning of a novel human melanocortin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Molecular cloning, functional expression and pharmacological characterization of a mouse melanocortin receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Cloning, expression, and tissue distribution of a fifth melanocortin receptor subtype

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Molecular cloning and characterization of the rat fifth melanocortin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Molecular cloning of a mouse melanocortin 5 receptor gene widely expressed in peripheral tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Melanotropin bioassays: in vitro and in vivo comparisons

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

alpha-Melanotropin: the minimal active sequence in the frog skin bioassay

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Design, synthesis, and conformation of superpotent and prolonged acting melanotropins

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Cyclic melanotropins. 9. 7-D-Phenylalanine analogues of the active-site sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Relative stability of alpha-melanotropin and related analogues to rat brain homogenates

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Calcium-dependent prolonged effects on melanophores of [4-norleucine, 7-D-phenylalanine]-alpha-melanotropin

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Inhibition by melittin and fluphenazine of melanotropin receptor function and adenylate cyclase in M2R melanoma cell membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Alpha-melanocyte stimulating hormone message and inhibitory sequences: comparative structure-activity studies on melanocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin recep

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Design and synthesis of somatostatin analogues with topographical properties that lead to highly potent and specific mu opioid receptor antagonists with greatly reduced binding at somatostatin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

A topographical model of mu-opioid and brain somatostatin receptor selective ligands. NMR and molecular dynamics studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

A colorimetric assay for measuring activation of Gs- and Gq-coupled signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

High-efficiency transformation of mammalian cells by plasmid DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

In vitro bioassay for the melanocyte stimulating hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Cocaine place preference is blocked by the delta-opioid receptor antagonist, naltrindole

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Suppression of immune function by non-peptidic delta opioid receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Selective antagonists at the opiate delta-receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

In vivo evidence for the selectivity of ICI 154129 for the delta-opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

ICI 174864: A highly selective antagonist for the opioid Δ-receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

TIPP[psi], a highly selective delta ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

TIPP[psi]: a highly potent and stable pseudopeptide delta opioid receptor antagonist with extraordinary delta selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

New delta-opioid antagonists as pharmacological probes.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Selective opioid dipeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

(2S,3R)TMT-L-Tic-OH is a potent inverse agonist at the human delta-opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

Isolation of an organ specific protein antigen from cell-surface membrane of rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2943127-8

7 January 2021

10.1016/S0076-6879(02)43127-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11665587%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference